The Silent Swell - Epidemiology, Clinical Profile, and Treatment patterns of benign prostate hyperplasia in India
Abstract
Background and Aim: benign prostatic hyperplasia (BPH) is a common age-related condition that significantly impacts the quality of life of older men, leading to lower urinary tract symptoms (LUTS) and potential complications. An understanding of the disease burden and management strategies in this population is crucial for optimizing healthcare delivery. The study aimed to evaluate the demographic and clinical characteristics and treatment patterns in Indian patients diagnosed with BPH. Methods: The retrospective, multi-centric, cross-sectional design involved the collection of data from various healthcare facilities across India. Results: The study population comprised 3,182 individuals with a mean age of 65.1 years, Common comorbidities included erectile dysfunction (20.0%) and hypertension (10.8%) and diabetes (8.1). 91.1% patients were managed by medical measures while 8.9% of cases required surgical intervention, most commonly TURP. 65.8% of patients received standard BPH medications (alpha blockers), while 30% patients received dual therapy with an alpha blocker and a 5-ARI. Silodosin (45%), Tamsulosin (40%) were most common alpha blockers while Dutasteride (95%) was most common 5-Alpha Reductase Inhibitor (ARI) used in Indian settings. IPSS scores, mean baseline PSA (8.83 ng/ml), and mean PVR volume (151.38 ml) all decreased post-treatment indicating improved symptoms and bladder emptying. This highlights the effectiveness of the management strategies used in this…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 3,182 participants or records.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.